{"id":"W2086036058","doi":"10.1007/s10549-010-1152-0","title":"Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Eli Lilly (Canada); University of Alberta; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Placebo; Hazard ratio; Breast cancer; Taxane; Oncology; Anthracycline; Cancer; Colorectal cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001910963,0.002839128,0.006358998,0.000669839,0.0006701982,0.001370667,0.001494597,0.002264983,0.00927057],"category_scores_gemma":[0.002517057,0.001466817,0.001977375,0.0006298907,0.002106802,0.001720288,0.0005335995,0.004809056,0.001510191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001136524,"about_ca_system_score_gemma":0.001611519,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001838425,"about_ca_topic_score_gemma":0.003710278,"domain_scores_codex":[0.9992883,0.000331258,0.00004304763,0.0001759711,0.00004162785,0.0001199683],"domain_scores_gemma":[0.9986841,0.0004024664,0.0002390412,0.0001264783,0.00007407135,0.0004738729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9902914,0.004173724,0.0001071416,0.0001947012,0.0002905478,0.00001511264,0.00002210964,0.0001470895,0.001058407,0.00004921183,0.0002298529,0.003420629],"study_design_scores_gemma":[0.9717878,0.0272494,0.0003281197,0.000007796235,0.0001297258,0.000008400417,0.000008217819,0.0001679616,0.0001189251,0.00004997675,0.000137043,0.000006654885],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844803,0.00362178,0.00103213,0.0009181586,0.001401991,0.005023655,0.001032242,0.0001972748,0.002292445],"genre_scores_gemma":[0.9787472,0.003166995,0.001976678,0.001385302,0.000944066,0.006019148,0.001161416,0.00005009798,0.006549106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00927057,"threshold_uncertainty_score":0.03101319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07088188007729243,"score_gpt":0.4236067742751553,"score_spread":0.3527248941978628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}